New Checkpoint Inhibitors Under Investigation in CLL

September 29, 2016
Nitin Jain, MD

Nitin Jain, MD, assistant professor, Department of Leukemia, Division of Cancer Medicine, MD Anderson Cancer Center, discusses the checkpoint inhibitors under investigation in chronic lymphocytic leukemia (CLL).